Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika Zodda

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Elife|November 28, 2023
Autonomous metabolic reprogramming and oxidative stress characterize endothelial dysfunction in acute myocardial infarctionErika Zodda, Olga Tura-Ceide, Nicholas L Mills, et al.
Hypertension (Dallas, Tex. : 1979)|August 27, 2019
Differentially Expressed Proteins in Primary Endothelial Cells Derived From Patients With Acute Myocardial InfarctionSarath Babu Nukala, Luca Regazzoni, Giancarlo Aldini, et al.
Plos Computational Biology|January 3, 2018
Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cellsIgor Marín de Mas, Esther Aguilar, Erika Zodda, et al.
Frontiers in Molecular Biosciences|February 7, 2019
Metabolic Alterations in Cardiopulmonary Vascular DysfunctionValérie Françoise Smolders, Erika Zodda, Paul H A Quax, et al.
Cardiovascular Drugs and Therapy|February 20, 2021
Generation of a Novel In Vitro Model to Study Endothelial Dysfunction from Atherothrombotic SpecimensSusan Gallogly, Takeshi Fujisawa, John D Hung, et al.
Journal of Medical Virology|February 4, 2025
Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization InhibitorsErika Zodda, Mònica Pons, Natàlia DeMoya-Valenzuela, et al.
Oncogene|July 22, 2025
Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cellsMíriam Tarrado-Castellarnau, Carles Foguet, Josep Tarragó-Celada, et al.
Stem Cells (Dayton, Ohio)|May 6, 2016
Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition ProgramEsther Aguilar, Igor Marin de Mas, Erika Zodda, et al.
Oncotarget|November 16, 2017
MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cellsLourdes Sánchez-Cid, Mònica Pons, Juan José Lozano, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Elife|November 28, 2023
Autonomous metabolic reprogramming and oxidative stress characterize endothelial dysfunction in acute myocardial infarctionErika Zodda, Olga Tura-Ceide, Nicholas L Mills, et al.
Hypertension (Dallas, Tex. : 1979)|August 27, 2019
Differentially Expressed Proteins in Primary Endothelial Cells Derived From Patients With Acute Myocardial InfarctionSarath Babu Nukala, Luca Regazzoni, Giancarlo Aldini, et al.
Plos Computational Biology|January 3, 2018
Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cellsIgor Marín de Mas, Esther Aguilar, Erika Zodda, et al.
Frontiers in Molecular Biosciences|February 7, 2019
Metabolic Alterations in Cardiopulmonary Vascular DysfunctionValérie Françoise Smolders, Erika Zodda, Paul H A Quax, et al.
Cardiovascular Drugs and Therapy|February 20, 2021
Generation of a Novel In Vitro Model to Study Endothelial Dysfunction from Atherothrombotic SpecimensSusan Gallogly, Takeshi Fujisawa, John D Hung, et al.
Journal of Medical Virology|February 4, 2025
Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization InhibitorsErika Zodda, Mònica Pons, Natàlia DeMoya-Valenzuela, et al.
Oncogene|July 22, 2025
Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cellsMíriam Tarrado-Castellarnau, Carles Foguet, Josep Tarragó-Celada, et al.
Stem Cells (Dayton, Ohio)|May 6, 2016
Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition ProgramEsther Aguilar, Igor Marin de Mas, Erika Zodda, et al.
Oncotarget|November 16, 2017
MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cellsLourdes Sánchez-Cid, Mònica Pons, Juan José Lozano, et al.
Pageof 1